Oxygenta Pharmaceutical Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Mar '26 Mar 6, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Market Capitalization	1,844	2,942	971	520	342	74	Upgrade
Market Cap Growth	-41.99%	203.13%	86.75%	52.18%	358.63%	-	Upgrade
Enterprise Value	2,560	3,548	1,514	1,108	854	496	Upgrade
Last Close Price	49.86	79.56	28.99	36.60	24.05	7.30	Upgrade
PE Ratio	-	-	-	-	-	2.54	Upgrade
PS Ratio	1.63	2.69	2.45	1.68	0.56	0.14	Upgrade
PB Ratio	-5.03	-11.76	-4.82	-1.12	-0.99	-0.20	Upgrade
P/OCF Ratio	-	113.05	-	-	-	-	Upgrade
EV/Sales Ratio	2.27	3.25	3.82	3.58	1.41	0.95	Upgrade
EV/EBITDA Ratio	-	-	-	-	57.83	12.91	Upgrade
EV/EBIT Ratio	-	-	-	-	-	18.74	Upgrade
Debt / Equity Ratio	-1.99	-2.49	-2.84	-1.47	-1.50	-1.26	Upgrade
Debt / EBITDA Ratio	-	-	-	-	35.32	12.46	Upgrade
Net Debt / Equity Ratio	-1.95	-2.49	-2.84	-1.47	-1.50	-1.25	Upgrade
Net Debt / EBITDA Ratio	-3.84	-6.53	-5.91	-9.54	35.21	12.35	Upgrade
Net Debt / FCF Ratio	-	-7.08	-3.34	-6.02	-7.84	-5.67	Upgrade
Asset Turnover	-	1.49	0.68	0.73	1.86	1.98	Upgrade
Inventory Turnover	-	6.26	3.19	3.17	5.82	5.17	Upgrade
Quick Ratio	-	0.11	0.29	0.31	0.22	0.12	Upgrade
Current Ratio	-	0.36	0.72	0.76	1.19	0.91	Upgrade
Return on Assets (ROA)	-	-8.82%	-13.14%	-13.41%	-0.22%	6.30%	Upgrade
Return on Invested Capital (ROIC)	-51.76%	-27.85%	-42.00%	-46.98%	-0.86%	-	Upgrade
Return on Capital Employed (ROCE)	-	426.40%	-41.90%	-42.90%	-0.50%	16.20%	Upgrade
Earnings Yield	-9.46%	-3.29%	-3.58%	-22.26%	-1.79%	39.34%	Upgrade
FCF Yield	-	-2.99%	-17.67%	-21.70%	-19.40%	-112.30%	Upgrade
Buyback Yield / Dilution	-4.33%	-12.20%	-125.61%	-11.43%	-24.92%	-24.84%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.